Filing Details
- Accession Number:
- 0000899243-21-007812
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-23 16:30:18
- Reporting Period:
- 2021-02-19
- Accepted Time:
- 2021-02-23 16:30:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1788919 | Christoph Heinz Maeusli | C/O Lantheus Holdings, Inc. 331 Treble Cove Road North Billerica MA 01862 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-19 | 1,000 | $19.39 | 14,211 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020
Billionaire Hedge Funds
